Compare BWB & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWB | EMBC |
|---|---|---|
| Founded | 2005 | 1924 |
| Country | United States | United States |
| Employees | 322 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 526.4M | 524.1M |
| IPO Year | N/A | 2021 |
| Metric | BWB | EMBC |
|---|---|---|
| Price | $18.36 | $9.24 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $21.67 | $18.50 |
| AVG Volume (30 Days) | 57.6K | ★ 697.7K |
| Earning Date | 04-21-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 6.56% |
| EPS Growth | N/A | ★ 20.90 |
| EPS | N/A | ★ 0.74 |
| Revenue | N/A | N/A |
| Revenue This Year | $24.57 | $1.17 |
| Revenue Next Year | $12.35 | N/A |
| P/E Ratio | $12.97 | ★ $12.36 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.35 | $8.47 |
| 52 Week High | $20.30 | $15.55 |
| Indicator | BWB | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 49.90 | 48.55 |
| Support Level | $16.03 | $8.60 |
| Resistance Level | $19.34 | $9.36 |
| Average True Range (ATR) | 0.42 | 0.32 |
| MACD | -0.03 | 0.04 |
| Stochastic Oscillator | 29.30 | 46.15 |
Bridgewater Bancshares Inc is a financial holding company. Through its subsidiary, it offers various personal and commercial banking products and services such as savings accounts, certificates of deposits, money transfer services, digital wallets, credit and debit cards, safe deposit lockers, different types of loans and advances, commercial deposit accounts, treasury management, and others. The company principally focuses on catering to commercial clients, offering a suite of loan and deposit products. Geographically, it mainly operates in the Twin Cities Metropolitan Statistical Area in the United States.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.